Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Diagnostic yield and therapeutic impact of open lung biopsy in the critically ill patient.

Philipponnet C, Cassagnes L, Pereira B, Kemeny JL, Devouassoux-Shisheboran M, Lautrette A, Guerin C, Souweine B.

PLoS One. 2018 May 25;13(5):e0196795. doi: 10.1371/journal.pone.0196795. eCollection 2018.

2.

Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer.

Drouet Y, Treilleux I, Viari A, Léon S, Devouassoux-Shisheboran M, Voirin N, de la Fouchardière C, Manship B, Puisieux A, Lasset C, Moyret-Lalle C.

Sci Rep. 2018 May 9;8(1):7386. doi: 10.1038/s41598-018-25631-1.

3.

Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.

Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Int J Gynecol Cancer. 2018 Mar;28(3):493-499. doi: 10.1097/IGC.0000000000001202.

PMID:
29466254
4.

[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].

Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I.

Bull Cancer. 2018 Mar;105(3):299-314. doi: 10.1016/j.bulcan.2017.10.032. French.

PMID:
29397916
5.

Chondroid nodule in the female peritoneum arises from normal tissue and not from teratoma or conception product.

Franceschi T, Allias F, Mauduit C, Bolze PA, Devouassoux-Shisheboran M.

Virchows Arch. 2018 Jul;473(1):115-119. doi: 10.1007/s00428-018-2295-3. Epub 2018 Jan 24.

PMID:
29368082
6.

Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors.

Croce S, Ducoulombier A, Ribeiro A, Lesluyes T, Noel JC, Amant F, Guillou L, Stoeckle E, Devouassoux-Shisheboran M, Penel N, Floquet A, Arnould L, Guyon F, Mishellany F, Chakiba C, Cuppens T, Zikan M, Leroux A, Frouin E, Farre I, Genestie C, Valo I, MacGrogan G, Chibon F.

Mod Pathol. 2018 May;31(5):816-828. doi: 10.1038/modpathol.2017.185. Epub 2018 Jan 12.

PMID:
29327710
7.

Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.

Gouy S, Saidani M, Maulard A, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Oncologist. 2018 Mar;23(3):324-327. doi: 10.1634/theoncologist.2017-0310. Epub 2017 Dec 14.

PMID:
29242280
8.

Is uterine preservation combined with bilateral salpingo-oophorectomy to promote subsequent fertility safe in infiltrative mucinous ovarian cancer?

Gouy S, Saidani M, Maulard A, Faron M, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Gynecol Oncol Rep. 2017 Sep 28;22:52-54. doi: 10.1016/j.gore.2017.09.011. eCollection 2017 Nov.

9.

Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types.

Gouy S, Saidani M, Maulard A, Faron M, Bach-Hamba S, Bentivegna E, Leary A, Pautier P, Devouassoux-Shisheboran M, Genestie C, Morice P.

Gynecol Oncol Rep. 2017 Sep 1;22:21-25. doi: 10.1016/j.gore.2017.08.006. eCollection 2017 Nov.

10.

Cancer de l’ovaire : prise en charge pluridisciplinaire du cancer de l’ovaire en première ligne: Recommandations Saint-Paul-de-Vence 2016.

Classe JM, Guyon F, Falandry C, Devouassoux-Shisheboran M, Selle F, Joly F.

Bull Cancer. 2017 May;104 Suppl 1:S6-S15. doi: 10.1016/S0007-4551(17)30157-1. French.

PMID:
28625315
11.

The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade.

Foy JP, Bertolus C, Michallet MC, Deneuve S, Incitti R, Bendriss-Vermare N, Albaret MA, Ortiz-Cuaran S, Thomas E, Colombe A, Py C, Gadot N, Michot JP, Fayette J, Viari A, Van den Eynde B, Goudot P, Devouassoux-Shisheboran M, Puisieux A, Caux C, Zrounba P, Lantuejoul S, Saintigny P.

Ann Oncol. 2017 Aug 1;28(8):1934-1941. doi: 10.1093/annonc/mdx210.

12.

Networking for ovarian rare tumors: a significant breakthrough improving disease management.

Chiannilkulchai N, Pautier P, Genestie C, Bats AS, Vacher-Lavenu MC, Devouassoux-Shisheboran M, Treilleux I, Floquet A, Croce S, Ferron G, Mery E, Pomel C, Penault-Llorca F, Lefeuvre-Plesse C, Henno S, Leblanc E, Lemaire AS, Averous G, Kurtz JE, Ray-Coquard I.

Ann Oncol. 2017 Jun 1;28(6):1274-1279. doi: 10.1093/annonc/mdx099.

PMID:
28398524
13.

A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.

Morel AP, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, Devouassoux-Shisheboran M, Combaret V, Finetti P, Chassot C, Pinatel C, Fauvet F, Saintigny P, Thomas E, Moyret-Lalle C, Lachuer J, Despras E, Jauffret JL, Bertucci F, Guitton J, Wierinckx A, Wang Q, Radosevic-Robin N, Penault-Llorca F, Cox DG, Hollande F, Ansieau S, Caramel J, Birnbaum D, Vigneron AM, Tissier A, Charafe-Jauffret E, Puisieux A.

Nat Med. 2017 May;23(5):568-578. doi: 10.1038/nm.4323. Epub 2017 Apr 10.

PMID:
28394329
14.

PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes.

Bolze PA, Patrier S, Massardier J, Hajri T, Abbas F, Schott AM, Allias F, Devouassoux-Shisheboran M, Freyer G, Golfier F, You B.

Int J Gynecol Cancer. 2017 Mar;27(3):554-561. doi: 10.1097/IGC.0000000000000892.

PMID:
28060141
15.

Multidisciplinary management of advanced ovarian cancer for an optimal therapeutic strategy.

Heudel PE, Devouassoux-Shisheboran M, Taieb S, Genestie C, Selle F, Morice P, Rouzier R, Ray-Coquard I.

Eur J Gynaecol Oncol. 2017;38(2):175-180. Review.

PMID:
29953774
16.

Placental histological lesions in fetal and neonatal alloimmune thrombocytopenia: A retrospective cohort study of 21 cases.

Dubruc E, Lebreton F, Giannoli C, Rabilloud M, Huissoud C, Devouassoux-Shisheboran M, Allias F.

Placenta. 2016 Dec;48:104-109. doi: 10.1016/j.placenta.2016.10.009. Epub 2016 Oct 17.

PMID:
27871460
17.

Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.

Meurgey A, Descotes F, Mery-Lamarche E, Devouassoux-Shisheboran M.

Virchows Arch. 2017 Feb;470(2):225-229. doi: 10.1007/s00428-016-2038-2. Epub 2016 Nov 9.

PMID:
27830327
18.

Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors.

Liegl-Atzwanger B, Heitzer E, Flicker K, Müller S, Ulz P, Saglam O, Tavassoli F, Devouassoux-Shisheboran M, Geigl J, Moinfar F.

Mod Pathol. 2016 Oct;29(10):1262-77. doi: 10.1038/modpathol.2016.107. Epub 2016 Jul 1.

19.

[Glandular lesions of the uterine cervix: Pre-test].

Devouassoux-Shisheboran M.

Ann Pathol. 2016 Jun;36(3):176-8. doi: 10.1016/j.annpat.2016.04.001. Epub 2016 May 27. French. No abstract available.

PMID:
27240950
20.

[Glandular lesions of the uterine cervix: Case 6].

Devouassoux-Shisheboran M, Paoletti MT.

Ann Pathol. 2016 Jun;36(3):199-203. doi: 10.1016/j.annpat.2016.03.003. Epub 2016 May 27. French. No abstract available.

PMID:
27240949
21.

[Glandular lesions of the uterine cervix: Introduction].

Devouassoux-Shisheboran M.

Ann Pathol. 2016 Jun;36(3):174-5. doi: 10.1016/j.annpat.2016.03.007. Epub 2016 May 26. French. No abstract available.

PMID:
27237605
22.

The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells.

Jacqueroud L, Bouard C, Richard G, Payen L, Devouassoux-Shisheboran M, Spicer DB, Caramel J, Collin G, Puisieux A, Tissier A, Ansieau S.

Neoplasia. 2016 May;18(5):317-327. doi: 10.1016/j.neo.2016.03.007.

23.

[Glandular lesions of the uterine cervix: Pre-test answers].

Devouassoux-Shisheboran M.

Ann Pathol. 2016 Jun;36(3):179-80. doi: 10.1016/j.annpat.2016.04.002. Epub 2016 May 25. French. No abstract available.

PMID:
27236352
24.

[Glandular lesions of the uterine cervix: Case 8].

Penault-Llorca F, Devouassoux-Shisheboran M.

Ann Pathol. 2016 Jun;36(3):207-9. doi: 10.1016/j.annpat.2016.03.010. Epub 2016 May 25. French. No abstract available.

PMID:
27236351
25.

[Glandular lesions of the uterine cervix: Case 5].

Devouassoux-Shisheboran M, Arcin-Thoury F.

Ann Pathol. 2016 Jun;36(3):195-8. doi: 10.1016/j.annpat.2016.03.008. Epub 2016 May 25. French. No abstract available.

PMID:
27236349
26.

[Glandular lesions of the uterine cervix: Case 7].

Penault-Llorca F, Devouassoux-Shisheboran M.

Ann Pathol. 2016 Jun;36(3):204-6. doi: 10.1016/j.annpat.2016.03.002. Epub 2016 May 25. French. No abstract available.

PMID:
27236347
27.

Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus.

Plissonnier ML, Lahlali T, Michelet M, Lebossé F, Cottarel J, Beer M, Neveu G, Durantel D, Bartosch B, Accardi R, Clément S, Paradisi A, Devouassoux-Shisheboran M, Einav S, Mehlen P, Zoulim F, Parent R.

PLoS Biol. 2016 Mar 31;14(3):e1002421. doi: 10.1371/journal.pbio.1002421. eCollection 2016 Mar.

28.

[Pseudosarcomatous chorangioma: A macroscopic and microscopic atypical tumor].

Allias F, Lebreton F, Gaillot-Durand L, Jaouen A, Reis Borges R, Devouassoux-Shisheboran M.

Ann Pathol. 2016 Apr;36(2):120-4. doi: 10.1016/j.annpat.2015.11.013. Epub 2016 Mar 15. French.

PMID:
26993586
29.

The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.

Durieux E, Descotes F, Mauduit C, Decaussin M, Guyetant S, Devouassoux-Shisheboran M.

Virchows Arch. 2016 May;468(5):631-6. doi: 10.1007/s00428-016-1922-0. Epub 2016 Mar 16. Review.

PMID:
26983701
30.

[Dualistic classification of epithelial ovarian cancer: Is it clinically relevant?].

Devouassoux-Shisheboran M, Genestie C, Ray-Coquard I.

Bull Cancer. 2016 Mar;103(3):252-8. doi: 10.1016/j.bulcan.2015.12.005. Epub 2016 Feb 4. Review. French.

PMID:
26853278
31.

Metallosis-associated prosthetic joint infection.

Barba T, Wach J, Lustig S, Laurent F, Devouassoux-Shisheboran M, Valour F, Chidiac C, Ferry T; Lyon BJI Study Group.

Med Mal Infect. 2015 Nov-Dec;45(11-12):484-7. doi: 10.1016/j.medmal.2015.09.009. Epub 2015 Nov 14. No abstract available.

PMID:
26584840
32.

SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas.

Le Loarer F, Watson S, Pierron G, de Montpreville VT, Ballet S, Firmin N, Auguste A, Pissaloux D, Boyault S, Paindavoine S, Dechelotte PJ, Besse B, Vignaud JM, Brevet M, Fadel E, Richer W, Treilleux I, Masliah-Planchon J, Devouassoux-Shisheboran M, Zalcman G, Allory Y, Bourdeaut F, Thivolet-Bejui F, Ranchere-Vince D, Girard N, Lantuejoul S, Galateau-Sallé F, Coindre JM, Leary A, Delattre O, Blay JY, Tirode F.

Nat Genet. 2015 Oct;47(10):1200-5. doi: 10.1038/ng.3399. Epub 2015 Sep 7.

PMID:
26343384
33.

KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GIST.

Klinke OK, Mizani T, Baldwin G, Bancel B, Devouassoux-Shisheboran M, Scoazec JY, Bringuier PP, Feederle R, Jauch A, Hinderhofer K, Taniere P, Delecluse HJ.

PLoS One. 2015 Jun 23;10(6):e0130149. doi: 10.1371/journal.pone.0130149. eCollection 2015.

34.

DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.

Goulvent T, Ray-Coquard I, Borel S, Haddad V, Devouassoux-Shisheboran M, Vacher-Lavenu MC, Pujade-Laurraine E, Savina A, Maillet D, Gillet G, Treilleux I, Rimokh R.

Histopathology. 2016 Jan;68(2):279-85. doi: 10.1111/his.12747. Epub 2015 Jul 21.

PMID:
26033501
35.

[Initial management of advanced ovarian cancer: What radiological, pathological and surgical information are important for optimal therapeutic strategy?].

Heudel PE, Selle F, Morice P, Rouzier R, Taieb S, Devouassoux-Shisheboran M, Genestie C, Balleyguier C, Ray-Coquard I.

Bull Cancer. 2015 Sep;102(9):772-9. doi: 10.1016/j.bulcan.2015.04.011. Epub 2015 May 28. Review. French.

PMID:
26028492
36.

French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.

Lantuejoul S, Rouquette I, Blons H, Le Stang N, Ilie M, Begueret H, Grégoire V, Hofman P, Gros A, Garcia S, Monhoven N, Devouassoux-Shisheboran M, Mansuet-Lupo A, Thivolet F, Antoine M, Vignaud JM, Penault-Llorca F, Galateau-Sallé F, McLeer-Florin A.

Eur Respir J. 2015 Jul;46(1):207-18. doi: 10.1183/09031936.00119914. Epub 2015 Apr 30.

37.

Somatic DICER1 gene mutation in sporadic intraocular medulloepithelioma without pleuropulmonary blastoma syndrome.

Durieux E, Descotes F, Nguyen AM, Grange JD, Devouassoux-Shisheboran M.

Hum Pathol. 2015 May;46(5):783-7. doi: 10.1016/j.humpath.2015.01.020. Epub 2015 Feb 19.

PMID:
25791583
38.

Erratum to: Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management.

Guerin C, Bayle F, Leray V, Debord S, Stoian A, Yonis H, Roudaut JB, Bourdin G, Devouassoux-Shisheboran M, Bucher E, Ayzac L, Lantuejoul S, Philipponnet C, Kemeny JL, Souweine B, Richard JC.

Intensive Care Med. 2015 Feb;41(2):387. doi: 10.1007/s00134-015-3657-9. No abstract available.

PMID:
25591993
39.

Pathobiology of ovarian carcinomas.

Devouassoux-Shisheboran M, Genestie C.

Chin J Cancer. 2015 Jan;34(1):50-5. doi: 10.5732/cjc.014.10273. Review.

40.

[Gestational trophoblastic disease].

Allias F, Bolze PA, Gaillot-Durand L, Devouassoux-Shisheboran M; réseau des maladies trophoblastiques gestationnelles.

Ann Pathol. 2014 Dec;34(6):434-47. doi: 10.1016/j.annpat.2014.09.004. Epub 2014 Nov 14. Review. French.

PMID:
25499859
41.

Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient management.

Guerin C, Bayle F, Leray V, Debord S, Stoian A, Yonis H, Roudaut JB, Bourdin G, Devouassoux-Shisheboran M, Bucher E, Ayzac L, Lantuejoul S, Philipponnet C, Kemeny JL, Souweine B, Richard JC.

Intensive Care Med. 2015 Feb;41(2):222-30. doi: 10.1007/s00134-014-3583-2. Epub 2014 Dec 5. Erratum in: Intensive Care Med. 2015 Feb;41(2):387.

PMID:
25476984
42.

Is breast cancer overdiagnosis also nested in pathologic misclassification?

Colin C, Devouassoux-Shisheboran M, Sardanelli F.

Radiology. 2014 Dec;273(3):652-5. doi: 10.1148/radiol.14141116. No abstract available.

PMID:
25420166
43.

Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.

Fujiwara H, Yokota H, Monk B, Treilleux I, Devouassoux-Shisheboran M, Davis A, Kim JW, Mahner S, Stany M, Pignata S, Ray-Coquard I, Fujiwara K.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S96-101. doi: 10.1097/IGC.0000000000000263. Review.

PMID:
25341589
44.

Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.

Hasegawa K, Nagao S, Yasuda M, Millan D, Viswanathan AN, Glasspool RM, Devouassoux-Shisheboran M, Covens A, Lorusso D, Kurzeder C, Kim JW, Gladieff L, Bryce J, Friedlander M, Fujiwara K.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S90-5. doi: 10.1097/IGC.0000000000000297. Review.

PMID:
25341588
45.

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.

Berton-Rigaud D, Devouassoux-Shisheboran M, Ledermann JA, Leitao MM, Powell MA, Poveda A, Beale P, Glasspool RM, Creutzberg CL, Harter P, Kim JW, Reed NS, Ray-Coquard I.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S55-60. doi: 10.1097/IGC.0000000000000228. Review.

PMID:
25341582
46.

Gynecologic Cancer InterGroup (GCIG) consensus review for small cell carcinoma of the cervix.

Satoh T, Takei Y, Treilleux I, Devouassoux-Shisheboran M, Ledermann J, Viswanathan AN, Mahner S, Provencher DM, Mileshkin L, Åvall-Lundqvist E, Pautier P, Reed NS, Fujiwara K.

Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S102-8. doi: 10.1097/IGC.0000000000000262. Review.

PMID:
25341572
47.

Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC).

Confavreux CB, Girard N, Pialat JB, Bringuier PP, Devouassoux-Shisheboran M, Rousseau JC, Isaac S, Thivolet-Bejui F, Clezardin P, Brevet M.

Bonekey Rep. 2014 Oct 1;3:580. doi: 10.1038/bonekey.2014.75. eCollection 2014.

48.

Adenocarcinoma of the uterine cervix: why is it different?

Fujiwara K, Monk B, Devouassoux-Shisheboran M.

Curr Oncol Rep. 2014 Dec;16(12):416. doi: 10.1007/s11912-014-0416-y. Review.

PMID:
25325935
49.

Small metastasizing choroidal melanomas.

Malclès A, Kivelä T, Svetlosakova Z, Jean-Louis B, Nguyen AM, Sallit R, Négrier S, Pommier P, Rivoire M, Chauvel P, Mammar H, Devouassoux-Shisheboran M, Kodjikian L, Denis P, Grange JD.

Acta Ophthalmol. 2015 Mar;93(2):e160-6. doi: 10.1111/aos.12523. Epub 2014 Aug 13.

50.

[Microscopic extensions of head and neck squamous cell carcinomas: impact for clinical target volume definition].

Fleury B, Thariat J, Barnoud R, Buiret G, Lebreton F, Bancel B, Poupart M, Devouassoux-Shisheboran M.

Cancer Radiother. 2014 Nov;18(7):666-71. doi: 10.1016/j.canrad.2014.04.006. Epub 2014 Jun 26. French.

PMID:
24981411

Supplemental Content

Loading ...
Support Center